Maria Jose Contreras-Zarate

10PUBLICATIONS
18CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2026
Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases.

|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.

|May 13, 2026
Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis.

|Mar 27, 2026
Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusions.

Maria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz

|Jul 16, 2025
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of ER+ breast cancer brain metastases in young and aged hosts.

Morgan S Fox, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz

|Apr 13, 2023
Short-term topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis.

Maria J Contreras-Zárate, Karen L F Alvarez-Eraso, Jenny A Jaramillo-Gómez

Pageof 2

Frequent Collaborators

8 joint publications

Diana M Cittelly

6 joint publications

R Alejandro Márquez-Ortiz

4 joint publications

Jenny A Jaramillo-Gómez

4 joint publications

Stella Koliavas